In Focus
Automated Insulin Delivery
Advances in continuous glucose monitoring (CGM) has led to a paradigm shift in the management of type 1 diabetes. The developments have enabled the automation of insulin delivery, where an algorithm determines the insulin delivery rate in response to the CGM values. There are numerous automated insulin delivery (AID) systems under development, some of which are becoming fully-fledged and mature, following which the future designs may incorporate additional hormones and several inputs, such as the activity level or monitoring other diabetic symptoms. The future CGM devices must show to be sufficiently accurate to be safely incorporated into AID.
